Chronic Endometritis

2
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
2
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Genesis Therapeutics
Genesis TherapeuticsCA - Burlingame
2 programs
2
Intrauterine infusionPhase 21 trial
Oral antibiotic administrationPhase 21 trial
Active Trials
NCT05205993UnknownEst. Apr 2024
NCT04447625CompletedEst. Jan 2020

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Genesis TherapeuticsIntrauterine infusion
Genesis TherapeuticsOral antibiotic administration

Clinical Trials (2)

NCT05205993Genesis TherapeuticsIntrauterine infusion

Εffectiveness of Intrauterine Antibiotic Administration for Treatment of Chronic Endometritis

Start: Jan 2021Est. completion: Apr 2024
Phase 2Unknown
NCT04447625Genesis TherapeuticsOral antibiotic administration

Intrauterine Antibiotic Infusion in Treating Chronic Endometritis and Restoring Reproductive Dynamics

Start: Mar 2017Est. completion: Jan 2020
Phase 2Completed

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space